VitaNova Life Sciences (VNOV) Debt to Equity (2017 - 2025)

VitaNova Life Sciences (VNOV) reported Debt to Equity of $0.09 for Q1 2025, up 84.77% on a YoY basis from $0.05 in Q1 2024, and down 25.6% quarter-over-quarter from $0.12 in Q4 2024.

VitaNova Life Sciences (VNOV) Debt to Equity (2017 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Debt to Equity for 9 years, with the latest figure at $0.09 in Q1 2025.

  • For the quarter ending Q1 2025, Debt to Equity rose 84.77% year-over-year to $0.09; the trailing twelve-month figure through Jan 2025 stood at $0.09 (up 84.77% YoY), and the FY2024 full-year result was $0.0, up 101.04% from the prior year.
  • Debt to Equity for Q1 2025 stood at $0.09, down from $0.12 in the prior quarter.
  • The five-year high for Debt to Equity was $0.12 in Q4 2024, with the low at -$1.48 in Q1 2022.
  • Historically, Debt to Equity has averaged -$0.37 across 5 years, with a median of -$0.29 in 2023.
  • Annual changes were most pronounced in 2022 — Debt to Equity tumbled 50.94% — and 2024, when it jumped 170.25%.
  • VitaNova Life Sciences' Debt to Equity stood at -$0.71 in 2021, then surged by 43.48% to -$0.4 in 2022, then soared by 55.98% to -$0.18 in 2023, then soared by 170.25% to $0.12 in 2024, then retreated by 25.6% to $0.09 in 2025.
  • The last three Debt to Equity figures came in at $0.09 (Q1 2025), $0.12 (Q4 2024), and $0.06 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - 0.01
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn -3.69
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 3.45
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn -3.34
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 0.72
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn -4.53
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 1.89
8 111 107.47 Mn 25.61 Mn 23.58 Mn -0.26
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 0.46
10 VitaNova Life Sciences - - 316,343.00 -

Historic Data

Download Data
DateValue
Jan 31, 2025 0.09
Oct 31, 2024 0.12
Jul 31, 2024 0.06
Apr 30, 2024 0.00
Jan 31, 2024 0.05
Oct 31, 2023 -0.18
Apr 30, 2023 -0.27
Jan 31, 2023 -0.29
Oct 31, 2022 -0.40
Jul 31, 2022 -0.37
Apr 30, 2022 -0.35
Jan 31, 2022 -1.48
Oct 31, 2021 -0.71
Apr 30, 2021 -0.84
Jan 31, 2021 -0.98
Oct 31, 2020 -0.92
Jul 31, 2020 -0.78
Apr 30, 2020 -0.85
Jan 31, 2020 -0.97
Oct 31, 2019 -0.91